Clondalkin Group partners with Pharma Prospect
Posted on:
Clondalkin Group has joined forces with Spanish print manufacturer Pharma Prospect in a strategic alliance to develop and strengthen its Pharma and Healthcare business across Europe. Pharma Prospect, located in Barcelona, manufacture a full range of printed paper leaflets which are supported by extensive design, pre-press, supply chain management and packaging system services.
Clondalkin Group is a market leader in secondary healthcare packaging. The Group's Pharma & Healthcare division is a global supplier of cartons, labels and literature and operates 17 accredited Pharma & Healthcare sites throughout North America and Europe, including a market leading carton operation in Spain formerly known as Cartonplex, which is also based in Barcelona.
Malcolm Farnan, sales and marketing director from Clondalkin Group, comments, "We are very pleased to form this strategic alliance. Pharma Prospect specializes in the manufacture of print solutions to some of the world's leading manufacturers in the pharmaceutical, medical device, healthcare and cosmetic industries and therefore complement our own capabilities perfectly. Like us, they focus on providing innovative, value added packaging solutions and developing strong and long-lasting customer relationships.
"By working together and effectively promoting each other's skills and expertise, the agreement will enable both parties to realise new opportunities and strengthen our growth strategies in Europe," Malcolm says.
Tony Pirretas, director general at Pharma Prospect, adds, "This agreement will enable us to build a strong team in the Spanish pharmaceutical market. It will strengthen our credibilty and demonstrate to our customers our commmitment to become a market leading global packaging supplier."
Clondalkin Group's Specialist Packaging Division has 25 production sites throughout North America and Europe and includes folding cartons, labels, leaflets, literature and inserts/outserts businesses, along with paper packaging and printing components.
Clondalkin Group's Pharma & Healthcare Global CEO David Lennon concludes: "This alliance with Pharma Prospect is part of our stated objective to become the global leader in the supply of secondary packaging to the Pharma & Healthcare sector."
Source: Label & Narrow Web
Malcolm Farnan, sales and marketing director from Clondalkin Group, comments, "We are very pleased to form this strategic alliance. Pharma Prospect specializes in the manufacture of print solutions to some of the world's leading manufacturers in the pharmaceutical, medical device, healthcare and cosmetic industries and therefore complement our own capabilities perfectly. Like us, they focus on providing innovative, value added packaging solutions and developing strong and long-lasting customer relationships.
"By working together and effectively promoting each other's skills and expertise, the agreement will enable both parties to realise new opportunities and strengthen our growth strategies in Europe," Malcolm says.
Tony Pirretas, director general at Pharma Prospect, adds, "This agreement will enable us to build a strong team in the Spanish pharmaceutical market. It will strengthen our credibilty and demonstrate to our customers our commmitment to become a market leading global packaging supplier."
Clondalkin Group's Specialist Packaging Division has 25 production sites throughout North America and Europe and includes folding cartons, labels, leaflets, literature and inserts/outserts businesses, along with paper packaging and printing components.
Clondalkin Group's Pharma & Healthcare Global CEO David Lennon concludes: "This alliance with Pharma Prospect is part of our stated objective to become the global leader in the supply of secondary packaging to the Pharma & Healthcare sector."
Source: Label & Narrow Web
